Attendance and reimbursement increase when physicians and patients connect in online appointments.
Having a staff member call patients a day ahead of scheduled telehealth appointments paid off with better attendance and reimbursement for a health system.
Attendance improved by 9% and the return on investment totaled $11,387 over a 12-week period, according to the study, “Evaluation of Telehealth Visit Attendance After Implementation of a Patient Navigator Program.” The research was published in JAMA Network Open to explain the program from April to July 2021 at two academic primary care clinics of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center.
Hiring a patient helper was a cost-effective intervention that boosted telehealth attendance, cut patient no-shows and cancelations, and increased successful video visits over 12 weeks, the study said.
“Implementing a Telehealth Patient Navigator may be a high-value proposition for health care systems, as it uniquely benefits patients and clinicians while being cost-effective and yielding a positive net return on investment,” the study said.
Like many doctors, the participating physicians quickly integrated telehealth at the start of the COVID-19 pandemic. But with technical challenges, video visits sometimes needed to become telephone consultations, the study said.
Advertisement
In a pilot program, a patient navigator was hired and trained to call patients a day before video appointments, aiming to improve access to care by reducing technological barriers for those new to the online visits. The navigator, reaching patients with morning and afternoon appointments, covered the steps for patients to connect with their physicians.
Those patients, along with those in a comparator group, all received typical appointment reminders, such as phone calls or text messages, the study said.
There were 4,068 patients involved, and outcomes were not known for two of them. The navigator reached 1,035 patients, with 949 of them, or 91.6%, successfully attending their appointments. There were 60 cancelations for a rate of 5.8%, and 26 patients, or 2.5%, missed their appointments.
Among the remaining 3,031 patients in the comparator group, 2,511, or 82.8%, checked in for their visits; 279, or 9.2%, canceled; and 241, or 8%, never showed.
Based on the visitation rate and a $65 per revenue value unit reimbursement, the program covered the quarterly navigator salary of $17,878 and actualized a return on investment of $11,387 over 12 weeks, the study said.
The researchers noted patients’ willingness to answer the navigator’s calls could indicate a favorable view of technology, even if the patients did not have video visits before. During the pandemic, the rapid increase in telehealth and novelty of video visits likely contributed to the efficacy of the program.
As pandemic conditions improve, it is unclear if physicians and patients will continue using telehealth, and patient familiarity with technology could hurt the effectiveness of a navigator, the study said. But if telehealth continues for specific conditions, such as chronic illness management, the work of the navigator can be adapted to support those cases, the study said.
Other limitations include not fully knowing the qualities or qualifications that affect the navigator’s role, and language – the navigator’s outreach is limited to patients who speak the same language, the study said.
This article originally appeared on Medical Economics®.
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Study reveals critical gaps in care for PCOS patients
May 17th 2024A new study presented at the 2024 ACOG Annual Clinical and Scientific Meeting highlighted significant gaps in polycystic ovary syndrome (PCOS) care, revealing widespread patient dissatisfaction and the urgent need for improved provider education and comprehensive treatment approaches.
Read More
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Study reveals critical gaps in care for PCOS patients
May 17th 2024A new study presented at the 2024 ACOG Annual Clinical and Scientific Meeting highlighted significant gaps in polycystic ovary syndrome (PCOS) care, revealing widespread patient dissatisfaction and the urgent need for improved provider education and comprehensive treatment approaches.
Read More
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More
2 Commerce Drive
Cranbury, NJ 08512